Streetbeat News

Stock Prices

CVS

CVS Health reported Q1 2024 adjusted EPS of $1.31, missing the $1.69 estimate, and sales of $88.437B, missing the $89.209B estimate. This represents a 40.45% decrease in EPS and a 3.70% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:31 am

TSLA

XPEV

XPeng Inc. (NYSE:XPEV) reported a 33% year-on-year increase in vehicle deliveries for April, totaling 9,393 units, and a 4% increase over the previous month. The company highlighted the success of its XNGP ADAS and the X9 model, which is the top-selling all-electric MPV in China. Year-to-date, XPENG has delivered 31,214 Smart EVs, marking a 23% increase from the previous year. XPENG also introduced the AI Valet Driver feature and announced its new brand, MONA, set to launch in June 2024. Despite these announcements, XPEV shares are trading slightly lower at $8.12 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

May 01, 2024 | 10:25 am

CCJ

DNN

UEC

UUUU

Shares of uranium stocks, including CCJ, DNN, UEC, and UUUU, are trading higher following the US Senate's approval of a bill to ban Russian uranium imports. This legislative move is expected to reduce competition from Russian uranium, potentially increasing demand for uranium mined by these companies.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:21 am

AMZN

Amazon.com Inc. announced its generative AI business within AWS has reached a 'multibillion-dollar' revenue run rate, as revealed during the Q1 2024 earnings call. The company's overall revenue grew by 13%, with AWS revenue up 17% year-on-year. The strong demand for generative AI is expected to further fuel capital expenditure growth, with Amazon spending $14 billion in capex in Q1 2024. This growth comes after Amazon reported strong Q1 2024 earnings, with AWS hitting a $100 billion annual run rate.

Portfolio Pulse from Rounak Jain

May 01, 2024 | 10:16 am

TSLA

Tesla shares are trading lower after CEO Elon Musk announced plans to slow the expansion of new Supercharger locations, focusing instead on ensuring 100% uptime and expanding existing locations.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:16 am

GSK

GSK shares are trading higher following the announcement of better-than-expected Q1 results and an increase in its 2024 core operating profit guidance.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:13 am

DD

DuPont de Nemours shares surged following the announcement of stronger-than-anticipated Q1 financial results and an upgraded forecast for FY24.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:13 am

CVE

Cenovus Energy (NYSE:CVE) reported Q1 2024 earnings of C$0.62 per share, surpassing the C$0.53 estimate, marking a 93.75% increase from last year. However, their sales of C$13.400B fell short of the C$14.134B estimate, despite being a 47.74% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:11 am

AXTA

Axalta Coating has increased its FY24 adjusted EPS outlook to $1.90 - $2.00, up from the previous $1.80 - $1.95, surpassing the $1.89 estimate. The company expects Q2 2024 net sales growth of 3% - 5% and a low single-digit increase for the full year. Adjusted EBITDA is projected at approximately $275 million for Q2 and between $1,050 - $1,080 million for FY24. The adjusted diluted EPS for Q2 is estimated at around $0.50, with free cash flow projected between $425 - $475 million for the full year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:11 am

NAPA

The Duckhorn Portfolio announced its Q3 preliminary net sales to be between $91M-$93M, which is lower than the previous $102.4M.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:10 am